Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine rich repeat containing 37, member A3 pseudogene (LRRC37A3P) is a pseudogene, a non-functional genomic DNA sequence resembling a functional gene from the LRRC37 family. Pseudogenes like LRRC37A3P arise via gene duplication or retrotransposition events but have lost the ability to encode a functional protein due to disabling mutations. As with other pseudogenes, LRRC37A3P is not translated into functional protein and generally does not participate in normal physiological or disease processes. Its primary significance is as part of genome evolution and complexity; it is not considered a therapeutic target, biological regulator, or biomarker[2][4]. This entity is a pseudogene, not a valid drug target, has no known biological or disease function, and should not be considered for therapeutic targeting. Its existence is primarily of genetic and evolutionary rather than functional or pharmacological interest[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine rich repeat containing 37, member A3 pseudogene (LRRC37A3P).